The Cystic Fibrosis Foundation (CFF) has joined 70 other organizations in signing a letter opposing the latest version of the Right to Try Act, which the House passed recently. It would allow terminally ill Americans to try medicines that have passed Phase 1 of the U.S. Food and Drug Administration…
cystic fibrosis
Quantification of two specific molecules in urine can help in the early detection of kidney damage triggered by treatment with aminoglycosides in patients with cystic fibrosis (CF), a study suggests. This finding was reported in the study “Urinary Biomarkers of Aminoglycoside-Induced Nephrotoxicity in Cystic Fibrosis: Kidney Injury…
The U.S. Food and Drug Administration has granted Fast Track Designation to Proteostasis Therapeutics’ triple combo treatment program for cystic fibrosis. The program includes the company’s amplifier, corrector, and potentiator of the CFTR gene — a combination designed to overcome the impact of the mutations that cause CF. The…
AbbVie has opened applications for its 2018-2019 academic-year scholarships for undergraduate and graduate students with cystic fibrosis. The program awards $3,000 to 40 students, based on their academic excellence, creativity and community service. The 40 winners can also compete for a $25,000 special award in two categories — Thriving Undergraduate…
Almost everyone with cystic fibrosis or pulmonary fibrosis would like to have a remote monitoring device that allows them to keep tabs on their lung function at home, online surveys of the two patient groups indicate. PMD Healthcare said it conducted the surveys to learn CF and PF patients’ views on lung…
US Patent Issued for AB569, Arch Biopartners’ Treatment Candidate for Chronic Respiratory Infections
AB569, Arch Biopartners’ treatment candidate for bacterial infections in patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), and other respiratory conditions, has received a U.S. patent. The U.S. Patent and Trademark Office issued patent 9,925,206 to the University of Cincinnati, which granted Arch Biopartners an…
GeneFo has put together an updated 2018 guide on treatment options for people with cystic fibrosis (CF) after recent developments again focused attention on the high price tag of some of these medications and the difficulties patients face in accessing them. The guide includes information on financial and clinical resources to…
The Boomer Esiason Foundation (BEF) recently received a $50,000 grant from the Investors Bank and the Investors Foundation in recognition of the nonprofit’s 25 years of dedicated service to the cystic fibrosis (CF) community. The grant highlights the positive partnership built by Investors Bank and former…
Facemasks are just as good as mouthpieces and noseclips for breathing test measurements in preschool-age children, a study found. Multiple breath washout (MBW), a test that uses this equipment, measures lung function, making it possible to detect early lung disease. The study, “Comparison of facemask and mouthpiece…
Many cystic fibrosis patients have long-term Staphylococcus aureus infections, with the bacteria’s resistance to antibiotics fluctuating over time, a study reports. Chronic and recurrent infection of the airways is the most severe consequence of cystic fibrosis. The most prevalent bacteria is Staphylococcus aureus. There are different types of it, however, and studies have…
Your CF Community

Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.
Recent Posts
- Inhaled therapy ETD001 well tolerated in healthy volunteers December 15, 2025
- This winter solstice, I reflect on moving from darkness to light December 12, 2025
- Safety concerns halt BX004 phage therapy trial for CF infection December 9, 2025
- Trikafta cuts need long-term for other CF treatments in real world December 8, 2025
- We shouldn’t have to fight so hard for healthcare coverage December 8, 2025